Literature DB >> 18936327

Molecular imaging of activated matrix metalloproteinases in vascular remodeling.

Jiasheng Zhang1, Lei Nie, Mahmoud Razavian, Masood Ahmed, Lawrence W Dobrucki, Abolfazl Asadi, D Scott Edwards, Michael Azure, Albert J Sinusas, Mehran M Sadeghi.   

Abstract

BACKGROUND: Matrix metalloproteinase (MMP) activation plays a key role in vascular remodeling. RP782 is a novel indium (111)In-labeled tracer with specificity for activated MMPs. We hypothesized that RP782 can detect injury-induced vascular remodeling in vivo. METHODS AND
RESULTS: Left common carotid artery injury was induced with a guidewire in apolipoprotein E(-/-) mice. Sham surgery was performed on the contralateral artery, which served as control for imaging experiments. Carotid wire injury led to significant hyperplasia and expansive remodeling over a period of 4 weeks. MMP activity, detected by in situ zymography, increased in response to injury and was maximal by 3 to 4 weeks after injury. RP782 (11.1 MBq) was injected intravenously into apolipoprotein E(-/-) mice at 1, 2, 3, and 4 weeks after left carotid injury. MicroSPECT imaging was performed at 2 hours and was followed by CT angiography to localize the carotid arteries. In vivo images revealed focal uptake of RP782 in the injured carotid artery at 2, 3, and 4 weeks. Increased tracer uptake in the injured artery was confirmed by quantitative autoradiography. Pretreatment with 50-fold excess nonlabeled tracer significantly reduced RP782 uptake in injured carotids, thus demonstrating uptake specificity. Weekly changes in the vessel-wall area closely paralleled and correlated with RP782 uptake (Spearman r=0.95, P=0.001).
CONCLUSIONS: Injury-induced MMP activation in the vessel wall can be detected by RP782 microSPECT/CT imaging in vivo. RP782 uptake tracks the hyperplastic process in vascular remodeling and provides an opportunity to track the remodeling process in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18936327      PMCID: PMC2637824          DOI: 10.1161/CIRCULATIONAHA.108.789743

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  39 in total

1.  A clearer vision for in vivo imaging.

Authors:  R Weissleder
Journal:  Nat Biotechnol       Date:  2001-04       Impact factor: 54.908

2.  In vivo molecular target assessment of matrix metalloproteinase inhibition.

Authors:  C Bremer; C H Tung; R Weissleder
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

Review 3.  New functions for the matrix metalloproteinases in cancer progression.

Authors:  Mikala Egeblad; Zena Werb
Journal:  Nat Rev Cancer       Date:  2002-03       Impact factor: 60.716

Review 4.  Nuclear medicine applications in molecular imaging.

Authors:  Francis G Blankenberg; H William Strauss
Journal:  J Magn Reson Imaging       Date:  2002-10       Impact factor: 4.813

Review 5.  Molecular imaging of cancer with positron emission tomography.

Authors:  Sanjiv Sam Gambhir
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

6.  Imaging experimental atherosclerotic lesions in ApoE knockout mice: enhanced targeting with Z2D3-anti-DTPA bispecific antibody and 99mTc-labeled negatively charged polymers.

Authors:  Ban-An Khaw; Yared Tekabe; Lynne L Johnson
Journal:  J Nucl Med       Date:  2006-05       Impact factor: 10.057

7.  Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model.

Authors:  C Bremer; S Bredow; U Mahmood; R Weissleder; C H Tung
Journal:  Radiology       Date:  2001-11       Impact factor: 11.105

8.  Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor.

Authors:  C Fernandez-Patron; M W Radomski; S T Davidge
Journal:  Circ Res       Date:  1999-11-12       Impact factor: 17.367

Review 9.  Plasmin and matrix metalloproteinases in vascular remodeling.

Authors:  H R Lijnen
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

Review 10.  Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

Authors:  Zorina S Galis; Jaikirshan J Khatri
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

View more
  48 in total

Review 1.  The year in molecular imaging.

Authors:  Eric A Osborn; Farouc A Jaffer
Journal:  JACC Cardiovasc Imaging       Date:  2010-11

2.  Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease.

Authors:  Jae-Joon Jung; Mahmoud Razavian; Azariyas A Challa; Lei Nie; Reza Golestani; Jiasheng Zhang; Yunpeng Ye; Kerry S Russell; Simon P Robinson; Donald D Heistad; Mehran M Sadeghi
Journal:  J Nucl Med       Date:  2015-04-23       Impact factor: 10.057

3.  State-of-the-Art Methods for Evaluation of Angiogenesis and Tissue Vascularization: A Scientific Statement From the American Heart Association.

Authors:  Michael Simons; Kari Alitalo; Brian H Annex; Hellmut G Augustin; Craig Beam; Bradford C Berk; Tatiana Byzova; Peter Carmeliet; William Chilian; John P Cooke; George E Davis; Anne Eichmann; M Luisa Iruela-Arispe; Eli Keshet; Albert J Sinusas; Christiana Ruhrberg; Y Joseph Woo; Stefanie Dimmeler
Journal:  Circ Res       Date:  2015-04-30       Impact factor: 17.367

4.  Capping it off.

Authors:  H William Strauss
Journal:  J Nucl Cardiol       Date:  2009-07-25       Impact factor: 5.952

Review 5.  PET and SPECT in cardiovascular molecular imaging.

Authors:  Lawrence W Dobrucki; Albert J Sinusas
Journal:  Nat Rev Cardiol       Date:  2009-11-24       Impact factor: 32.419

6.  Targeted imaging of matrix metalloproteinase activity in the evaluation of remodeling tissue-engineered vascular grafts implanted in a growing lamb model.

Authors:  Mitchel R Stacy; Yuji Naito; Mark W Maxfield; Hirotsugu Kurobe; Shuhei Tara; Chung Chan; Kevin A Rocco; Toshiharu Shinoka; Albert J Sinusas; Christopher K Breuer
Journal:  J Thorac Cardiovasc Surg       Date:  2014-05-21       Impact factor: 5.209

7.  The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodeling.

Authors:  Kristopher B Deatrick; Catherine E Luke; Megan A Elfline; Vikram Sood; Joseph Baldwin; Gilbert R Upchurch; Farouc A Jaffer; Thomas W Wakefield; Peter K Henke
Journal:  J Vasc Surg       Date:  2013-03-13       Impact factor: 4.268

8.  Synthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical Probes.

Authors:  Thomas Bordenave; Marion Helle; Fabrice Beau; Dimitris Georgiadis; Livia Tepshi; Mylène Bernes; Yunpeng Ye; Laure Levenez; Enora Poquet; Hervé Nozach; Mahmoud Razavian; Jakub Toczek; Enrico A Stura; Vincent Dive; Mehran M Sadeghi; Laurent Devel
Journal:  Bioconjug Chem       Date:  2016-09-14       Impact factor: 4.774

9.  Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors.

Authors:  Matthias Nahrendorf; Peter Waterman; Greg Thurber; Kevin Groves; Milind Rajopadhye; Peter Panizzi; Brett Marinelli; Elena Aikawa; Mikael J Pittet; Filip K Swirski; Ralph Weissleder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-16       Impact factor: 8.311

Review 10.  Multimodal iron oxide nanoparticles for hybrid biomedical imaging.

Authors:  Timo Heidt; Matthias Nahrendorf
Journal:  NMR Biomed       Date:  2012-10-15       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.